Investors / United States / Agent Capital
Agent Capital
Venture capital · Waltham, MA, United States · North America
Agent Capital is a healthcare venture capital firm that makes direct equity investments in novel, differentiated therapeutics and treatments addressing unmet patient needs. It invests from preclinical through commercial stages and participates in early and later stage financing rounds.
Invests inHealthcare & Biotech
In its own wordshealthcarebiotechtherapeuticsrare diseasesoncologyimmunology
Your fit with Agent Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsAgent Capital lists 35 checked portfolio companies on its own site and is named in 6 funding rounds. Its most frequent entry is Growth, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (87%), AI & Machine Learning (8%) and Enterprise Software (5%). 93% of its companies are based in United States. It invests most often alongside RA Capital, Catalio Capital Management and BrightEdge.
Counts come from funding rounds that name Agent Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not Agent Capital's whole history. Rounds on record name 6 companies; its own site lists 35. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 17% |
| Series A | 33% |
| Series B | 0% |
| Growth | 50% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 1 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 0 |
| '26 | 4 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 73th | 35 companies |
| Recent activity | 86th | 5 rounds in 12 months |
| Early stage | 57th | 17% of entries at pre-seed or seed |
| Evidence | 80th | 11% of companies confirmed by a round |
| Sector focus | 95th | 87% in its largest sector |
| Reach | 59th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| RA Capital | 6 |
| Catalio Capital Management | 4 |
| BrightEdge | 3 |
| Casdin Capital | 3 |
| Foresite Capital | 3 |
| Osage University Partners | 3 |
| Sanofi Ventures | 3 |
| ShangBay Capital | 3 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers3291%
- No longer answers00%
- Points to another company39%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 87% | 15% |
| AI & Machine Learning | 8% | 18% |
| Enterprise Software | 5% | 8% |
Co-investor network
who it backs companies with, and who they back togetherCompare Agent Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Funds
from public registers and its siteRecent portfolio activity
when companies last raised with Agent Capital| Date | Company | Stage |
|---|---|---|
| 23 Oct 2026 | Series C+ | |
| 22 Sept 2026 | Series C+ | |
| 28 Jul 2026 | Series A | |
| 30 Jun 2026 | Series C+ | |
| 8 Dec 2025 | Seed | |
| 26 Apr 2023 | Series A |
Round details for Agent Capital
Amounts, full round histories and every co-investor in Agent Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
35 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Portfolio page | ||||
| Alveus Therapeutics develops treatments for obesity and weight loss maintenance | Healthcare & Biotech | Portfolio page | ||
| AshiBio is developing novel therapies for patients with bone and connective tissue disorders | Healthcare & Biotech | Portfolio page | ||
| Cerevance develops therapies for neurodegenerative disorders, including Parkinson's disease. | Healthcare & Biotech | Portfolio page | ||
| Cofounder provides an AI platform to help run and manage various aspects of a company, including engineering, sales, marketing, and finance. | AI & Machine LearningEnterprise Software | Dec 2025Seed | Funding round | |
| Cyrus Biotechnology is a computationally-driven discovery company focused on developing therapeutics from naturally existing proteins using computational modeling and deep mutagenesis. | Healthcare & Biotech | Portfolio page | ||
| Dragonfly develops advanced immunotherapies for diseases with high unmet need | Healthcare & Biotech | Portfolio page | ||
| Entrada Therapeutics is working to treat devastating diseases with intracellular therapeutics | Healthcare & Biotech | Portfolio page | ||
| Flare Therapeutics designs small molecules to treat disease, particularly cancer, by regaining transcriptional control hijacked by cancer cells. | Healthcare & Biotech | Jun 2026Series C+ | Page + round | |
| Foresight Diagnostics develops and delivers innovative diagnostic tests that combine precision genomics and cutting-edge bioinformatics to advance cancer drug development and patient care. | Healthcare & Biotech | Portfolio page | ||
| Freenome develops blood-based screening tests to detect cancer at its earliest stages | Healthcare & Biotech | Portfolio page | ||
| GlycoEra develops biologics to selectively target and degrade specific circulating proteins that drive diseases such as autoantibodies in immune-driven disorders | Healthcare & Biotech | Portfolio page | ||
| Hinge Bio develops next-generation therapeutics for difficult to treat diseases | Healthcare & Biotech | Portfolio page | ||
| Immunitas Therapeutics discovers and develops novel therapeutics for patients with cancer and autoimmune diseases. | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Portfolio page | |||
| Mediar Therapeutics is developing treatments for fibrotic diseases by targeting the myofibroblast cell | Healthcare & Biotech | Portfolio page | ||
| Metagenomi is an in vivo genome editing company creating curative genetic medicines for patients | Healthcare & Biotech | Portfolio page | ||
| Nu-Tek Biosciences manufactures specialty yeast extracts, peptones, and hydrolysates for cell culture media | Healthcare & Biotech | Portfolio page | ||
Healthcare & Biotech | Apr 2023Series A | Page + round | ||
| Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- agentcapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Rounds since
- 26 Apr 2023
- Companies checked
- 35
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Agent Capital's profile as data
Pull Agent Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/agentcapital.com
# also
GET /v1/firms/agentcapital.com/portfolio
GET /v1/firms/agentcapital.com/coinvestors
GET /v1/firms/agentcapital.com/news